<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): October 30, 2008</B>


<P style="font-size: 24pt" align="center"><B>HEARTWARE LIMITED<BR>
</B><FONT
style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>State of Victoria,
Australia</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>000-52595</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>98-0498958</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Level 57<BR>
MLC
Centre<BR>
19-29 Martin Place<BR>
Sydney NSW 2000<BR>
Australia<BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>&nbsp;</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>+61 2 9238 2064</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;7.01 Regulation&nbsp;FD
Disclosure</B>

<P style="font-size: 10pt" align="justify">On October&nbsp;22, 2008 (Australian Eastern
Standard Time), HeartWare
Limited announced, via an Australian Securities Exchange (&#8220;ASX&#8221;)
announcement, that the Federal Court of Australia ordered that the Schemes of
Arrangement (<B>Schemes</B>) between HeartWare Limited (<B>Company</B>) and its
shareholders (<B>Share Scheme</B>), optionholders (<B>Option Scheme</B>) and
performance rights holders (<B>Performance Rights Scheme</B>) be approved.

<P style="font-size: 10pt" align="justify">The Schemes will become effective
once a copy of the Court orders have been lodged with the Australian Securities
and Investments Commission, which the Company intends to do on
October&nbsp;31, 2008 (<B>Effective Date</B>).

<P style="font-size: 10pt" align="justify">As at the close of business on the
Effective Date, the Company&#8217;s shares will be suspended from quotation on
ASX. The securities of HeartWare International, Inc. are expected to commence
trading on a deferred settlement basis on November 3, 2008, being the first
business day after the Effective Date.

<P style="font-size: 10pt" align="justify">The record date for determining
entitlements to consideration under the Schemes will be 7:00 PM on
November&nbsp;7, 2008.

<P style="font-size: 10pt" align="justify">The Schemes are expected to be
implemented on November&nbsp;11, 2008. No further action is required by
shareholders, optionholders and performance rights holders of the Company.

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;9.01 Financial
Statements and Exhibits</B>

<P style="font-size: 10pt" align="justify"><U>(d)&nbsp;Exhibits</U>

<P style="font-size: 10pt" align="justify">Exhibit&nbsp;99.1 ASX announcement,
Federal Court Approved for Schemes of Arrangement, dated
October&nbsp;30, 2008

<P style="font-size: 10pt" align="justify"><B>SIGNATURES</B>

<P style="font-size: 10pt" align="justify">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="45%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="40%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left" colspan="3">HeartWare Limited</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px"><BR>Date: October&nbsp;30, 2008
</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left"><BR>By: </TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left"><BR>/s/ David McIntyre</TD>
 </TR>
 <TR style="font-size: 1px">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD style="border-top: #000000 1px solid" valign="top"
align="left">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Name: David McIntyre</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Title: Chief Financial Officer and Chief
Business Officer</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c76509e8vk.htm", "description": "8-K", "secsgml_size_bytes": 8215}]
{"company-data": {"conformed-name": "HeartWare LTD", "cik": "0001389072", "assigned-sic": "3841", "irs-number": "980498958", "state-of-incorporation": "C3", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52595", "film-number": "081151978"}, "business-address": {"street1": "3351 EXECUTIVE WAY", "city": "MIRAMAR", "state": "FL", "zip": "33025", "phone": "954-874-1400"}, "mail-address": {"street1": "3351 EXECUTIVE WAY", "city": "MIRAMAR", "state": "FL", "zip": "33025"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): October 30, 2008
HEARTWARE LIMITED
(Exact name of registrant as specified in its charter)
State of Victoria,
Australia
000-52595
98-0498958
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
Level 57
MLC
Centre
19-29 Martin Place
Sydney NSW 2000
Australia
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
+61 2 9238 2064
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD
Disclosure
On October 22, 2008 (Australian Eastern
Standard Time), HeartWare
Limited announced, via an Australian Securities Exchange ("ASX")
announcement, that the Federal Court of Australia ordered that the Schemes of
Arrangement (
Schemes
) between HeartWare Limited (
Company
) and its
shareholders (
Share Scheme
), optionholders (
Option Scheme
) and
performance rights holders (
Performance Rights Scheme
) be approved.
The Schemes will become effective
once a copy of the Court orders have been lodged with the Australian Securities
and Investments Commission, which the Company intends to do on
October 31, 2008 (
Effective Date
).
As at the close of business on the
Effective Date, the Company's shares will be suspended from quotation on
ASX. The securities of HeartWare International, Inc. are expected to commence
trading on a deferred settlement basis on November 3, 2008, being the first
business day after the Effective Date.
The record date for determining
entitlements to consideration under the Schemes will be 7:00 PM on
November 7, 2008.
The Schemes are expected to be
implemented on November 11, 2008. No further action is required by
shareholders, optionholders and performance rights holders of the Company.
Item 9.01 Financial
Statements and Exhibits
(d) Exhibits
Exhibit 99.1 ASX announcement,
Federal Court Approved for Schemes of Arrangement, dated
October 30, 2008
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
HeartWare Limited
Date: October 30, 2008
By:
/s/ David McIntyre
Name: David McIntyre
Title: Chief Financial Officer and Chief
Business Officer